Kiora Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Capital Stock (Details)

Capital Stock (Details)						1 Months Ended							3 Months Ended
Capital Stock (Details)	Jan. 31, 2024 USD ($) day $ / shares shares	Aug. 07, 2023 USD ($) day $ / shares shares	Jun. 06, 2023 USD ($) $ / shares shares	Feb. 22, 2023 USD ($) shares	Feb. 03, 2023 USD ($) $ / shares shares	Feb. 29, 2024 USD ($) $ / shares shares	Nov. 30, 2023 USD ($) shares	Aug. 31, 2023 shares	Jul. 31, 2023 shares	Jun. 30, 2023 shares	Apr. 30, 2023 USD ($) shares	Feb. 28, 2023 shares	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)
Class of Stock [Line Items]
Proceeds from issuance of private placement \| $													$ 15,000,000	$ 200,000
Proceeds from issuance of common stock \| $													0	98,960
Issuance of common stock from warrant exercises (in shares)												50,000
Net proceeds \| $			$ 5,600,000
Underwriting discount and commissions \| $			500,000
Underwriting discount and commissions expenses \| $			$ 200,000
Class of warrant or right, outstanding (in shares)		11,500,000
Warrant, down round feature, decrease in net income to common shareholder, amount \| $		$ 500,000
Exercise of warrants \| $							$ 8,600						$ 1,438,817	$ 298,500
Class C Warrant
Class of Stock [Line Items]
Issuance of common stock from warrant exercises (in shares)							8,200
Class C Warrants
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares						$ 0.5231
Issuance of common stock from warrant exercises (in shares)						915,155
Exercise of warrants \| $						$ 400,000
Class D Warrants
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares						$ 0.5231
Issuance of common stock from warrant exercises (in shares)						1,835,402	8,200
Exercise of warrants \| $						$ 1,000,000
Lincoln Park
Class of Stock [Line Items]
Proceeds from issuance of common stock \| $				$ 100,000							$ 300,000
Maxim Group LLC
Class of Stock [Line Items]
Net proceeds \| $	$ 13,800,000
Sale of stock, number of shares issued in transaction (in shares)	15,800,000
Maxim Group LLC \| Pre Funded Warrants
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)	11,354,237
Maxim Group LLC \| Tranche A Warrants and Tranche B Warrants
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)	49,374,590
Maxim Group LLC \| Tranche A Warrants
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)	24,687,295
Exercise price (in usd per share) \| $ / shares	$ 0.6076
Warrants and rights outstanding, term	5 years
Proceeds from issuance of warrants \| $	$ 15,000,000
Class of warrant or right, threshold trading days \| day	30
Class of warrant or right, volume weighted average price of common stock (in usd per share) \| $ / shares	$ 1.1048
Class of warrant or right, threshold consecutive trading days \| day	30
Maxim Group LLC \| Tranche B Warrants
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)	24,687,295
Exercise price (in usd per share) \| $ / shares	$ 0.6076
Warrants and rights outstanding, term	5 years
Proceeds from issuance of warrants \| $	$ 15,000,000
Class of warrant or right, threshold trading days \| day	30
Class of warrant or right, volume weighted average price of common stock (in usd per share) \| $ / shares	$ 1.3810
Class of warrant or right, threshold consecutive trading days \| day	30
Common Stock
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)								481,770	481,770	2,688,822
Common Stock \| Lincoln Park
Class of Stock [Line Items]
Issuance of common stock (in shares)				20,000							105,000
Equity line of credit (up to) \| $					$ 10,000,000
Series F Convertible Preferred Stock
Class of Stock [Line Items]
Conversion of stock, shares converted (in shares)								530	530	2,958
Private Placement
Class of Stock [Line Items]
Issuance of common stock (in shares)					52,798
Number of warrants issued to purchase the shares (in shares)					105,596
Proceeds from issuance of private placement \| $					$ 100,000
Warrants exercisable, anniversary of closing date					6 months
Warrants and rights outstanding, term					5 years
Private Placement \| Common Stock
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares					$ 3.538
Public Offering \| Class C and Class D Warrants
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares		$ 0.5231	$ 1.10
Warrants exercise price reduction, trading days, threshold, immediately following initial exercise day \| day		60
Exercise price reduction percentage of average of the VWAP for trading day period immediately prior to reset date		90.00%
Warrants exercise price reduction, trading days, threshold, prior to reset date \| day		5
Public Offering \| Class C Warrant
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			5,750,000
Public Offering \| Class D Warrant
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			5,750,000
Public Offering \| Common shares
Class of Stock [Line Items]
Issuance of common stock (in shares)			2,197,628
Number of warrants issued to purchase the shares (in shares)			3,552,372
Public Offering \| Series F Convertible Preferred Stock
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)			3,908
Public Offering \| Series F Convertible Preferred Stock \| 909 Class C and 909 Class D Warrants
Class of Stock [Line Items]
Purchase price (in usd per share) \| $ / shares			$ 999.90
Over-Allotment Option \| Class C Warrants, Exercise of Option
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			750,000
Over-Allotment Option \| Class D Warrant, Exercise Of Option
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			750,000
Over-Allotment Option \| Common Stock
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			750,000